ycopene supplementation in stable asthma

Phase 1

Completed

• Conditions: Asthma; Respiratory - Asthma

• Registration Number: ACTRN12606000286549
• Lead Sponsor: Hunter New England Health Service

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-07-07
• Study Completion: 2009-05-06
• Last Update Posted: 27 April 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 139

Inclusion Criteria

Stable asthma, Non-smokers

Exclusion Criteria

Other respiratory disease, Vitamin or mineral use.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Induced sputum neutrophil count[Measured at baseline, week 2,6,10 and 14.]

Secondary Outcome Measures

Name	Time	Method
Asthma Control Score[Measured at baseline, week 2,6,10 and 14.];Airway hyperresponsiveness [Measured at baseline, week 2,6,10 and 14.]